Product pipeline

science-innovation

Product pipeline

Through our pipeline, we are researching life-changing medicines that make birth, life and living possible.

Reproductive Medicine & Maternal Health

Title description Indication Phase 1 Phase 2 Phase 3 Phase 4
Evalute the effect of carbetocin on the QT/QTc interval in healthy subjects (TQT phase) Postpartum haemorrhage
ADAM: Assessment of follitropin delta efficacy and safety for treatment of men with idiopathic infertility Idiopathic male infertility
Rekovelle India: Multicentre trial in India comparing the efficacy and safety of follitropin delta with follitropin alfa in controlled ovarian stimulation in women undergoing ART Infertility
BEYOND (phase completed): Compare the efficacy and safety of individualised follitropin delta dosing, using a long GnRH agonist protocol and GnRH antagonist protocol in women undergoing controlled ovarian stimulation Infertility
ADAPT: Assessment of conventional dosing in women undergoing ART with follitropin delta treatment Infertility

Urology & Uro-oncology

Title description Indication Phase 1 Phase 2 Phase 3 Phase 4
Evaluate the safety and efficacy of Adstiladrin administered intravesically to Japanese subjects with high grade BCG-unresponsive non-muscle invasive bladder cancer High-risk non- muscle invasive bladder cancer (HR NMIBC)
Adstiladrin early utilisation and outcomes in the real-world setting in the U.S. Non-interventional real-world study High-risk non- muscle invasive bladder cancer (HR NMIBC)
Post-authorisation observational cohort safety study of hyponatraemia and cardiovascular and thromboembolic events in nocturia patients treated with Nocdurna Nocturia
Non-interventional, observational PAP data-based study to investigate the post-marketing safety by intensive monitoring of Firmagon in Chinese patients (phase completed) Prostate cancer

Gastroenterology & Microbiome

Title description Indication Phase 1 Phase 2 Phase 3 Phase 4
Explore the safety and clinical effectiveness of Rebyota administered by colonoscopy to adults with recurrent Clostridioides difficile infection Recurrent Clostridioides difficile infection
Pragmatic randomised controlled study of mesalazine and budesonide to assess the effectiveness of two patient management strategies in mild to moderate ulcerative colitis Ulcerative colitis
Evaluate the safety and tolerability of Rebyota (microbiota suspension) in subjects with recurrent Clostridioides difficile infection Recurrent Clostridioides difficile infection
Observational study of Rebyota for the prevention of recurrence of Clostridioides difficile infection in adult patients Recurrent Clostridioides difficile infection
Non-interventional study to describe the safety of Picolax (phase completed) Bowel preparation

This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.

OK

Cette page n'est pas destinée aux patients ou au grand public. Il est uniquement destiné à être utilisé par des professionnels de santé.

OK

Ik bevestig dat ik een professionele zorgverlener ben of een zakelijke relatie heb met Ferring Pharmaceuticals

OK

Ez az oldal nem betegeknek, vagy nagyközönségnek szól. Az oldalt kizárólag egészségügyi szakemberek használhatják.

OK

Ta strona nie jest przeznaczona dla pacjentów ani dla ogółu odwiedzających. Ta strona stworzona jest dla pracowników sektora ochrony zdrowia.

OK

Эта страница не предназначена для пациентов или для широкой публики. Она предназначена только для медицинских работников.

OK